151 related articles for article (PubMed ID: 7078263)
1. Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I.
Smithson WA; Perrault J
Mayo Clin Proc; 1982 May; 57(5):322-5. PubMed ID: 7078263
[TBL] [Abstract][Full Text] [Related]
2. Severe hemochromatosis: the predominant clinical manifestation of congenital dyserythropoietic anemia type 2.
Halpern Z; Rahmani R; Levo Y
Acta Haematol; 1985; 74(3):178-80. PubMed ID: 3938164
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of congenital dyserythropoietic anemia type I with long-term administration of deferoxamine].
Miyazawa K; Yoshikawa O; Takakuwa Y; Tuda A; Ohtaka M; Lin KY; Iguchi Y; Naruto M; Kondo M; Toyama K
Rinsho Ketsueki; 1988 Sep; 29(9):1454-9. PubMed ID: 3063858
[No Abstract] [Full Text] [Related]
4. [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis].
Kobayashi M; Yano K; Fujisawa S
Rinsho Ketsueki; 1996 Apr; 37(4):303-10. PubMed ID: 8847800
[TBL] [Abstract][Full Text] [Related]
5. [Congenital dyserythropoietic anemia: types I and II. Study of 2 cases].
Luño E; Jonte F; Sánchez-San Román F; Rojo JM
Sangre (Barc); 1985; 30(1):37-46. PubMed ID: 4002097
[No Abstract] [Full Text] [Related]
6. [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
Cario H; Grosse R; Janssen G; Jarisch A; Meerpohl J; Strauss G;
Klin Padiatr; 2010 Nov; 222(6):399-406. PubMed ID: 20862634
[TBL] [Abstract][Full Text] [Related]
7. Hereditary hemochromatosis in a patient with congenital dyserythropoietic anemia.
Fargion S; Valenti L; Fracanzani AL; Sampietro M; Cappellini MD; Scaccabarozzi A; Soligo D; Mariani C; Fiorelli G
Blood; 2000 Nov; 96(10):3653-5. PubMed ID: 11071669
[TBL] [Abstract][Full Text] [Related]
8. Long-term intraperitoneal deferoxamine for hemochromatosis.
Swartz RD; Legault DJ
Am J Med; 1996 Mar; 100(3):308-12. PubMed ID: 8629676
[TBL] [Abstract][Full Text] [Related]
9. [Leg ulcers in congenital dyserythropoietic anemia].
Gschnait F; Duschet P; Krieger O; Baumgartner G; Luger A; Stacher A
Z Hautkr; 1985 Jan; 60(1-2):199-203. PubMed ID: 3885599
[TBL] [Abstract][Full Text] [Related]
10. Iron overload in congenital erythrocyte pyruvate kinase deficiency.
Salem HH; Van Der Weyden MB; Firkin BG
Med J Aust; 1980 May; 1(11):531-2. PubMed ID: 7393032
[TBL] [Abstract][Full Text] [Related]
11. [Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis].
Kremp L; Girot R; Alliot S; Najean Y; Douchain F; Hongre JF
Arch Fr Pediatr; 1983; 40(6):475-7. PubMed ID: 6625846
[TBL] [Abstract][Full Text] [Related]
12. [Restrictive cardiac involvement in a patient with dyserythropoietic anemia and secondary hemochromatosis].
Barriales Alvarez V; Simarro García C; Suárez Suárez E; Rodríguez Blanco V; Segovia Martínez E; Barriales Villa R; Batalla Celorio A; Cortina Llosa A
Rev Esp Cardiol; 1996 Aug; 49(8):618-20. PubMed ID: 8756208
[TBL] [Abstract][Full Text] [Related]
13. A case of congenital dyserythropoietic anemia type II associated with hemochromatosis.
Tamura H; Matsumoto G; Itakura Y; Terai H; Ikebuchi K; Mitarai T; Isoda K
Intern Med; 1992 Mar; 31(3):380-4. PubMed ID: 1611191
[TBL] [Abstract][Full Text] [Related]
14. Congenital dyserythropoietic anemia type I with ringed sideroblasts.
Soysal T; Akun E; Ozaras R; Aki H; Ozturk M; Tuzuner N
Haematologia (Budap); 2000; 30(1):45-9. PubMed ID: 10841325
[TBL] [Abstract][Full Text] [Related]
15. [Secondary iron overload].
Galacteros F
Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():44-8. PubMed ID: 9827215
[No Abstract] [Full Text] [Related]
16. Neonatal hemochromatosis: failure of deferoxamine therapy.
Jonas MM; Kaweblum YA; Fojaco R
J Pediatr Gastroenterol Nutr; 1987; 6(6):984-8. PubMed ID: 3681586
[TBL] [Abstract][Full Text] [Related]
17. Successful Treatment of Iron-Overload Cardiomyopathy in Hereditary Hemochromatosis With Deferoxamine and Deferiprone.
Tauchenová L; Křížová B; Kubánek M; Fraňková S; Melenovský V; Tintěra J; Kautznerová D; Malušková J; Jirsa M; Kautzner J
Can J Cardiol; 2016 Dec; 32(12):1574.e1-1574.e3. PubMed ID: 27789107
[TBL] [Abstract][Full Text] [Related]
18. Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload.
Buchbinder D; Nugent D; Vu D; Soni A; Stites J; Hsieh L; Puthenveetil G
Pediatr Transplant; 2012 May; 16(3):E69-73. PubMed ID: 21108711
[TBL] [Abstract][Full Text] [Related]
19. Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two cases.
Kremer Hovinga JA; Solenthaler M; Dufour JF
Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1141-7. PubMed ID: 14501626
[TBL] [Abstract][Full Text] [Related]
20. [Isolated gonadotropin deficiency and secretory discrepancy of cortisol and adrenal androgen by hemochromatosis secondary to congenital dyserythropoietic anemia].
Okano J; Yanase T; Takayanagi R; Mimura K; Nawata H
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):57-64. PubMed ID: 7958084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
